anidulafungin has been researched along with Sensitivity and Specificity in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arastehfar, A; Berman, J; Boekhout, T; Kostrzewa, M; Lass-Flörl, C; Sparbier, K; Vatanshenassan, M | 1 |
| Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA | 1 |
| Kuti, JL; Nicolau, DP; Sutherland, CA | 1 |
| Bode-Böger, SM; Martens-Lobenhoffer, J; Rupprecht, V | 1 |
| Burhenne, H; Burkhardt, O; Kaever, V; Kielstein, JT | 1 |
| Cantón, E; Monteiro-Soares, M; Moreira-Rosário, A; Pina-Vaz, C; Rocha, R; Rodrigues, AG; Teixeira-Santos, R | 1 |
| Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J | 1 |
| Daschner, FD; Engels, I; Frank, U; Greiner, M | 1 |
| Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Holliday, NM; Killian, SB; Knapp, CC; Messer, SA; Miskov, A; Pfaller, MA; Ramani, R | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
10 other study(ies) available for anidulafungin and Sensitivity and Specificity
| Article | Year |
|---|---|
Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
Topics: Anidulafungin; Antifungal Agents; Blood Culture; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Glucosyltransferases; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2019 |
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole | 2015 |
Development of an HPLC method for the determination of anidulafungin in human plasma and saline.
Topics: Anidulafungin; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Stability; Echinocandins; Humans; Least-Squares Analysis; Lipopeptides; Micafungin; Reproducibility of Results; Sensitivity and Specificity; Sodium Chloride; Tandem Mass Spectrometry | 2011 |
Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification?
Topics: Anidulafungin; Antifungal Agents; Calibration; Chromatography, Reverse-Phase; Drug Monitoring; Drug Stability; Echinocandins; Humans; Least-Squares Analysis; Lipopeptides; Micafungin; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry | 2011 |
Quantitative analysis of the antifungal drug anidulafungin by LC-online SPE-MS/MS in human plasma.
Topics: Anidulafungin; Antifungal Agents; Chromatography, Liquid; Echinocandins; Humans; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tacrolimus; Tandem Mass Spectrometry | 2012 |
Novel method for evaluating in vitro activity of anidulafungin in combination with amphotericin B or azoles.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Barbiturates; Candida; Drug Synergism; Echinocandins; Flow Cytometry; Fluorescence; Fluorescent Dyes; Humans; Isoxazoles; Microbial Sensitivity Tests; Sensitivity and Specificity; Staining and Labeling | 2012 |
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole | 2003 |
Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes.
Topics: Anidulafungin; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Phagocytes; Phagocytosis; Respiratory Burst; Sampling Studies; Sensitivity and Specificity | 2004 |
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test | 1998 |